title: [Concomitant radiochemotherapy in rectal tumors].
abstract: Requirements for improved cancer control led to the testing of the combined-modality therapy for many types of cancer. This review attempts to analyse possibilities of the simultaneous application of both strategies in the treatment of rectal cancer. Postoperative radiochemotherapy has been shown to be effective in rectum carcinomas. Preoperative combined-modality therapy can ensure downstaging (T3, T4). Operation was carried out 4 to 6 weeks after the end of preoperative therapy.
authors.affiliation: Oddĕlení radiacní onkologie-Masarykův onkologický ústav, Brno. oro@mou.cz
authors.forename: P
authors.initials: P
authors.lastname: Slampa
authors.forename: P
authors.initials: P
authors.lastname: Coupek
authors.forename: R
authors.initials: R
authors.lastname: Soumarová
authors.forename: J
authors.initials: J
authors.lastname: Růzicková
authors.forename: H
authors.initials: H
authors.lastname: Horová
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D006801:Humans; D012004:Rectal Neoplasms / Q000532:radiotherapy / Q000628:therapy*
chemical_list: D000970:Antineoplastic Agents
vernacular_title: Konkomitantní radiochemoterapie nádorů konecníku.